Scinovex
articleTop 1% cited

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease

Archives of Neurology · 2006 · Vol. 63(11) · pp. 1545–1545
Ernst J. SchaeferVanina BongardAlexa BeiserStefania Lamon‐FavaSander J. RobinsRhoda AuKatherine L. TuckerDavid J. KylePeter W.F. WilsonPhilip A. Wolf

Abstract

The top quartile of plasma PC DHA level was associated with a significant 47% reduction in the risk of developing all-cause dementia in the Framingham Heart Study.

Fatty Acid Research and HealthFolate and B Vitamins ResearchBirth, Development, and HealthDementiaDocosahexaenoic acidInternal medicineQuartileConfidence intervalAlzheimer's diseaseMedicineRelative riskEndocrinologyGastroenterology

MeSH terms

AgedAged, 80 and overAlzheimer DiseaseDementiaDocosahexaenoic AcidsFemaleFollow-Up StudiesHumansMaleMental Status SchedulePhosphatidylcholinesProspective StudiesRiskIncidenceProportional Hazards Models

Funding

  • U.S. Department of Agriculture
  • Pfizer
  • University of Connecticut
  • National Institutes of Health
  • National Institute on Aging
  • National Heart, Lung, and Blood Institute
Citations
681
FWCI
27.88
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.